News
-
-
PRESS RELEASE
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Jaguar Health, Inc. announced the commercial launch of Neonorm Dog, a plant-based product for normal stool consistency and GI fluid balance in dogs, set to be available on Amazon and Chewy -
-
-
-
-
-
PRESS RELEASE
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
Jaguar Health receives $16M upfront payment in U.S. license agreement with Future Pak for crofelemer drugs. Presentation at ESPGHAN 2026 reveals positive results of crofelemer therapy for pediatric IF -
-